Media hub2025-06-26T15:48:32+00:00

Media hub

Advertising queries

Additional resources

Contact the media relations team

mediarelations@bmj.com
+44 (0)7825 118 107

Filter by

Search

Wegovy may have highest ‘eye stroke’ and sight loss risk of semaglutide GLP-1 agonists

2026-03-11T09:43:15+00:0011 March 2026|British Journal of Ophthalmology, Press release|Endocrinology and diabetology, Medical treatment|

GLP-1 diabetes drugs linked to reduced risk of addiction and substance-related death

2026-03-03T17:04:54+00:005 March 2026|Press release, The BMJ|brain and mental health, Endocrinology and diabetology, Medical treatment|

7 hours 18 mins may be optimal sleep length for avoiding type 2 diabetes precursor

2026-03-05T11:20:57+00:004 March 2026|BMJ Open Diabetes Research and Care, Press release|Endocrinology and diabetology, Physical health|